Gene Data From HGNC: https://www.genenames.org/download/statistics-and-files/
Symbol:
CR2
Name:
complement C3d receptor 2
Location:
01q32.2
Locus Group:
protein-coding gene
Gene Type:
Protein Coding
Locus Type:
gene with protein product
Clinical Trials Data: https://classic.clinicaltrials.gov/api/gui/ref/download_all
Clinical Studies
| NCT Number | Status | Brief Title | View |
|---|---|---|---|
| NCT03288233 | Exhaled Carbon Monoxide and Red Blood Cell Turnover | View | |
| NCT04229979 | Galinpepimut-S Versus Investigators Choice of Best Available Therapy for Maintenance in AML CR2CRp2 | View | |
| NCT04785547 | ALL SCTped 2012 FORUM Add-on Study Blina Post HSCT | View | |
| NCT01005979 | A Phase I Trial Using Cyclophosphamide Rituximab and Revlimid CR2 for the Treatment of RelapsedRefractory B-Cell Chronic Lymphocytic Leukemia B-CLL and Small Lymphocytic Lymphoma SLL | View | |
| NCT00957385 | Maintenance Therapy in Acute Myeloid Leukemia AML Patients | View | |
| NCT02274675 | A Pilot Study of Robot-assisted Therapy for Post-stroke Forearm and Wrist Rehabilitation Training | View | |
| NCT02361749 | Botulinum Toxin Injection Versus Anal Myectomy in Management of Idiopathic Constipation | View | |
| NCT04687176 | Frontline Oral Arsenic Trioxide for APL | View | |
| NCT03624270 | Oral Arsenic Trioxide for Newly Diagnosed Acute Promyelocytic Leukaemia | View | |
| NCT05690191 | Chidamide in Patients With Recurrent and Refractory Diffuse Large b | View | |
| NCT01435447 | FludarabineBusulfan and Cyclophosphamide Conditioning for Adult Lymphoid Malignancies | View | |
| NCT01513109 | Safety and Immunogenicity of Recombinant WT1 Antigen-Specific Cancer Immunotherapeutic Combined With Infusion of Treg Depleted T Cells for Adult WT1 Acute Myeloid Leukemia | View | |
| NCT00125606 | Phase 3 Trial for AML Patients in CR2 Comparing 8Gy TBI Fludarabine to Conditioning With TBI 12GyCyclophosphamide | View |